May Measurement Month 2018: an analysis of blood pressure screening results from Spain

Elevated blood pressure (BP) is the single most important contributing risk factor to the global disease burden, leading to over 10 million deaths each year. In Spain, hypertension (HTN) affects around 20% of the adult population and remains the greatest attributable cause of cardiovascular mortalit...

Descripción completa

Detalles Bibliográficos
Autores: Rodilla, E, Molinero, A, Gijon-Conde, T, Tous, S, Fornos, JA, Mera, I, Martinez, F, Carreras, B, de Berardinis, B, Beaney, T, Ster, AC, Poulter, NR, Xia, X, Ruilope, LM
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p10797
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/10797
Access Level:acceso abierto
Palabra clave:Blood pressure
Control
Hypertension screening
Treatment
id ES_bfdb1d2eadb21cfc751f3fb78d18c5f9
oai_identifier_str oai:fisabio.fundanetsuite.com:p10797
network_acronym_str ES
network_name_str España
repository_id_str
spelling May Measurement Month 2018: an analysis of blood pressure screening results from SpainRodilla, EMolinero, AGijon-Conde, TTous, SFornos, JAMera, IMartinez, FCarreras, Bde Berardinis, BBeaney, TSter, ACPoulter, NRXia, XRuilope, LMBlood pressureControlHypertension screeningTreatmentElevated blood pressure (BP) is the single most important contributing risk factor to the global disease burden, leading to over 10 million deaths each year. In Spain, hypertension (HTN) affects around 20% of the adult population and remains the greatest attributable cause of cardiovascular mortality. May Measurement Month (MMM) is a worldwide initiative aimed at increasing awareness of HTN and to improve the lack of screening programmes worldwide. An opportunistic cross-sectional survey of volunteers aged 18 and over was carried out in May 2018. Blood pressure measurement, the definition of HTN and statistical analysis followed the standard MMM protocol. Anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors were obtained as additional information. Screening sites mainly in community pharmacies, universities, primary care centres, HTN units, and cardiovascular departments in hospitals were set up across Spain as part of this initiative. In total, 7646 individuals (63.5% female) were screened during MMM18. After multiple imputation, 40.0% had HTN, of whom 74.4% were aware of their diagnosis and 69.6% were taking antihypertensive medication. Of individuals not receiving antihypertensive medication, 16.9% were hypertensive. Of individuals receiving antihypertensive medication, 36.4% had uncontrolled BP. MMM18 almost doubled the number of participants of MMM17 and was the largest BP screening campaign ever undertaken in Spain, showing that in the absence of systematic screening programmes for HTN, MMM can identify a great number of individuals at risk, increasing their awareness and attracting the interest of the healthcare system in Spain.OXFORD UNIV PRESS2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/10797EUROPEAN HEART JOURNAL SUPPLEMENTSISSN: 1520765XISSNe: 15542815reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p107972026-06-11T12:45:17Z
dc.title.none.fl_str_mv May Measurement Month 2018: an analysis of blood pressure screening results from Spain
title May Measurement Month 2018: an analysis of blood pressure screening results from Spain
spellingShingle May Measurement Month 2018: an analysis of blood pressure screening results from Spain
Rodilla, E
Blood pressure
Control
Hypertension screening
Treatment
title_short May Measurement Month 2018: an analysis of blood pressure screening results from Spain
title_full May Measurement Month 2018: an analysis of blood pressure screening results from Spain
title_fullStr May Measurement Month 2018: an analysis of blood pressure screening results from Spain
title_full_unstemmed May Measurement Month 2018: an analysis of blood pressure screening results from Spain
title_sort May Measurement Month 2018: an analysis of blood pressure screening results from Spain
dc.creator.none.fl_str_mv Rodilla, E
Molinero, A
Gijon-Conde, T
Tous, S
Fornos, JA
Mera, I
Martinez, F
Carreras, B
de Berardinis, B
Beaney, T
Ster, AC
Poulter, NR
Xia, X
Ruilope, LM
author Rodilla, E
author_facet Rodilla, E
Molinero, A
Gijon-Conde, T
Tous, S
Fornos, JA
Mera, I
Martinez, F
Carreras, B
de Berardinis, B
Beaney, T
Ster, AC
Poulter, NR
Xia, X
Ruilope, LM
author_role author
author2 Molinero, A
Gijon-Conde, T
Tous, S
Fornos, JA
Mera, I
Martinez, F
Carreras, B
de Berardinis, B
Beaney, T
Ster, AC
Poulter, NR
Xia, X
Ruilope, LM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Blood pressure
Control
Hypertension screening
Treatment
topic Blood pressure
Control
Hypertension screening
Treatment
description Elevated blood pressure (BP) is the single most important contributing risk factor to the global disease burden, leading to over 10 million deaths each year. In Spain, hypertension (HTN) affects around 20% of the adult population and remains the greatest attributable cause of cardiovascular mortality. May Measurement Month (MMM) is a worldwide initiative aimed at increasing awareness of HTN and to improve the lack of screening programmes worldwide. An opportunistic cross-sectional survey of volunteers aged 18 and over was carried out in May 2018. Blood pressure measurement, the definition of HTN and statistical analysis followed the standard MMM protocol. Anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors were obtained as additional information. Screening sites mainly in community pharmacies, universities, primary care centres, HTN units, and cardiovascular departments in hospitals were set up across Spain as part of this initiative. In total, 7646 individuals (63.5% female) were screened during MMM18. After multiple imputation, 40.0% had HTN, of whom 74.4% were aware of their diagnosis and 69.6% were taking antihypertensive medication. Of individuals not receiving antihypertensive medication, 16.9% were hypertensive. Of individuals receiving antihypertensive medication, 36.4% had uncontrolled BP. MMM18 almost doubled the number of participants of MMM17 and was the largest BP screening campaign ever undertaken in Spain, showing that in the absence of systematic screening programmes for HTN, MMM can identify a great number of individuals at risk, increasing their awareness and attracting the interest of the healthcare system in Spain.
publishDate 2020
dc.date.none.fl_str_mv 2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/10797
url https://fisabio.portalinvestigacion.com/publicaciones/10797
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv OXFORD UNIV PRESS
publisher.none.fl_str_mv OXFORD UNIV PRESS
dc.source.none.fl_str_mv EUROPEAN HEART JOURNAL SUPPLEMENTS
ISSN: 1520765X
ISSNe: 15542815
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418427036205056
score 15,812455

Similares en LA Referencia